Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Daiichi Sankyo Ltd ADR (DSNKY)

Daiichi Sankyo Ltd ADR (DSNKY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow 5.73
  • Price/Book 1.14
Trade DSNKY with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
28.7500 +2.89%
on 04/17/24
33.4300 -11.52%
on 03/22/24
-3.3800 (-10.25%)
since 03/18/24
3-Month
28.7500 +2.89%
on 04/17/24
35.0000 -15.49%
on 02/26/24
+0.2760 (+0.94%)
since 01/18/24
52-Week
23.7200 +24.70%
on 10/19/23
37.5662 -21.26%
on 06/13/23
-6.1900 (-17.31%)
since 04/18/23

Most Recent Stories

More News
300,000 New Cases: The Role of Biotech in Addressing Rising Breast Cancer Rates

USA News Group – Breast cancer rates are increasing this year, with nearly 300,000 new cases of invasive breast cancer diagnosed in women and 2,800 new cases in men. While breast cancer survival rates...

AZN : 68.36 (-0.25%)
ONCY : 1.0300 (-0.96%)
ONC.TO : 1.43 (-0.69%)
DSNKY : 29.5800 (+1.48%)
GILD : 66.16 (-1.15%)
ARAY : 2.21 (+0.91%)
Investing in Hope: Biotech Innovations Targeting Increased Breast Cancer Rates in 2023

USA News Group – Breast cancer rates are increasing this year, with nearly 300,000 new cases of invasive breast cancer diagnosed in women and 2,800 new cases in men. While breast cancer survival rates...

AZN : 68.36 (-0.25%)
ONCY : 1.0300 (-0.96%)
ONC.TO : 1.43 (-0.69%)
DSNKY : 29.5800 (+1.48%)
GILD : 66.16 (-1.15%)
ARAY : 2.21 (+0.91%)
Merck Just Made a Big Move -- but Will It Be Enough for Investors Right Now?

In due time, its new partnership with Daiichi Sankyo could be massive.

MRK : 125.23 (-0.11%)
DSNKY : 29.5800 (+1.48%)
Is Gilead Sciences a Good Stock to Buy Now?

Gilead Sciences' breast cancer drug, Trodelvy, just took a big step forward.

PFE : 25.39 (-0.12%)
DSNKY : 29.5800 (+1.48%)
GILD : 66.16 (-1.15%)
AZN : 68.36 (-0.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 30.6500
2nd Resistance Point 30.3200
1st Resistance Point 29.9500
Last Price 29.5800
1st Support Level 29.2500
2nd Support Level 28.9200
3rd Support Level 28.5500

See More

52-Week High 37.5662
Fibonacci 61.8% 32.2770
Fibonacci 50% 30.6431
Last Price 29.5800
Fibonacci 38.2% 29.0092
52-Week Low 23.7200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar